Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INEOX: Insulin Analogues and Oxidative Stress in T1D
NCT03328845Phase 4Completed
- Start
- Jan 2017
- Primary completion
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin degludec, insulin glargine in type 1 diabetes mellitus (T1D). Started Jan 2017; status: completed.
02
Drugs
insulin degludecinsulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03328845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03328845.